Positive Data Generated by Biosig Subsidiary ViralClear on Covid-19 Coronavirus Published in bioRxiv
April 09, 2020 08:22 ET
|
BioSig Technologies, Inc.
Westport, CT, April 09, 2020 (GLOBE NEWSWIRE) -- Vicromax shown to decrease viral production of Covid -19 coronavirus by over 98%Article highlights recent work done in laboratory studies of Covid...
BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19
April 03, 2020 13:10 ET
|
BioSig Technologies, Inc.
Westport, CT, April 03, 2020 (GLOBE NEWSWIRE) -- Introduction to ViralClear management and scientific teamStrategy for rapid FDA advancement of Vicromax(tm)Update on BioSig core business...
Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc.
March 31, 2020 08:45 ET
|
BioSig Technologies, Inc.
Westport, CT, March 31, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig subsidiary NeuroClear acquires license for a broad-spectrum anti-viral agent that may treat COVID-19. Laboratory results demonstrate high level of activity against COVID-19 in cell culture
March 25, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, March 25, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Florida Cardiologist Zachariah P. Zachariah, M.D. Joins BioSig Technologies, Inc. Advisory Board
March 10, 2020 08:05 ET
|
BioSig Technologies, Inc.
Westport, CT, March 10, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation
March 04, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, March 04, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig to Webcast its Presentation at the Cowen and Company’s 40th Annual Health Care Conference
March 03, 2020 12:20 ET
|
BioSig Technologies, Inc.
Westport, CT, March 03, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig to Present at the Cowen & Co. 40th Annual Health Care
February 26, 2020 08:33 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Announces Closing of Public Offering of Common Stock
February 25, 2020 15:25 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 25, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Announces $10 Million Public Offering of Common Stock
February 21, 2020 08:45 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...